Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19

Prior observational studies suggest that aspirin use may be associated with reduced mortality in high-risk hospitalized patients with COVID-19, but aspirin’s efficacy in patients with moderate COVID-19 is not well studied. To assess whether early aspirin use is associated with lower odds of in-hospital mortality in patients with moderate COVID-19.The primary outcome was 28-day in-hospital mortality, and secondary outcomes were pulmonary embolism and deep vein thrombosis.